December 12, 2024

“Back to the Future”: Developments in Immunotherapy with David Gandara, MD

December 12, 2024

Health IT Business News

April 25, 2024

Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing

June 20, 2024

New Clinical Study Identifies Personalized Treatment Options for Metastatic NSCLC With Plasma Proteome Testing

September 10, 2024

Proteomics and Prognostics May Serve as Potential Biomarkers Beyond PD-L1 in Lung Cancer

December 6, 2024

In Brief This Week

December 3, 2024

OncoHost Proteomics Lab Earns CAP Accreditation

December 3, 2024

OncoHost earns CAP accreditation for Cary laboratory

November 17, 2024

Bonus Features – November 17, 2024

November 14, 2024

OncoHost announces executive appointment of Ron Andrews

November 13, 2024

OncoHost Strengthens Leadership with Ron Andrews Appointment

November 13, 2024

OncoHost Hires Ron Andrews as Strategic Consultant to the CEO

November 13, 2024

Appointments and advancements for November 13, 2024

October 31, 2024

Editors' and Reader's Choice: 10 Favorite NoCamels Articles

September 13, 2024

OncoHost accepted to present poster at ESMO 2024

August 16, 2024

OncoHost announces three abstracts selected for presentation at WCLC 2024

July 30, 2024

Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection

August 2, 2024

Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

August 5, 2024

Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

July 29, 2024

New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients

June 18, 2024

Immunotherapy Month…and Much More

June 18, 2024

OncoHost: Finding New, Better Immunotherapies for Complex Cancers

May 27, 2024

Israeli Startup To Showcase AI Cancer Tool At Top Oncology Summit

May 27, 2024

PROphet Platform’s Predictive Ability to be Demonstrated

May 31, 2024

OncoHost To Present Poster Demonstrating PROphet®’s Application in Multiple Cancer Indications at ASCO 2024

June 10, 2024

Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research

June 12, 2024

Companies partner to identify biomarkers for renal cell carcinoma

June 3, 2024

OncoHost Launches Study on Biomarkers for Renal Cell Carcinoma

June 3, 2024

OncoHost and Dana-Farber Partner on Kidney Cancer (RCC) Biomarker Study

June 4, 2024

OncoHost announces new study on biomarkers for renal cell carcinoma

June 2, 2024

Leading Cancer institute Dana-Farber to partner with OncoHost for groundbreaking cancer study

May 17, 2024

OncoHost on liquid biopsy, AI, and developing Israel’s life sciences ecosystem

May 20, 2024

Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit

April 10, 2024

AI tool helps doctors pick optimum cancer treatment for patients

March 29, 2024

Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test

March 22, 2024

Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test

March 21, 2024

Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test

March 21, 2024

OncoHost Wins AI Excellence Award

February 26, 2024

Predicting immunotherapy success via biomarkers

February 22, 2024

New cancer research for personalized care

February 22, 2024

Study: Protein Indicates Likely Success of Cancer Immunotherapy

January 26, 2024

OncoHost’s CEO Is PROphet-ic About His Diagnostic’s Potential To Transform Care

January 15, 2024

OncoHost: Guiding oncology treatment decisions with one blood draw

January 4, 2024

Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon

April 4, 2022

AI & Big Data - A Bright New Diagnosis? Roundtable

December 8, 2019

First-Of-Its-Kind Lab To Improve Personalized Cancer Therapy Opens In Israel

December 31, 2019

Israeli algorithm may predict if cancer patients will respond to treatment

January 21, 2020

OncoHost, RayBiotech Win $1M From BIRD Foundation

January 21, 2020

OncoHost, RayBiotech Awarded $1 Million Grant for Precision Oncology

February 5, 2020

Top 5 Recent Advances In Israeli Cancer Research And Treatment

February 10, 2020

Startup develops blood test that aims to undermine tumors’ resilience

February 18, 2020

Backed by EU funds, Israeli researcher tackles treatment-resistant cancer

February 23, 2020

$8m in BIRD grants go to Israeli-US collaborations in agtech and health

March 1, 2020

Personalized Cancer Treatment, A Real Possibility?

April 7, 2020

Developing Personalized Strategies To Maximize Cancer Therapy Success

June 4, 2020

PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

June 4, 2020

PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

August 7, 2020

By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients?

October 6, 2020

OncoHost Data on Host Immunotherapy Response to be Presented This Week

November 4, 2020

Oncohost platform improves immunotherapy response predictions

November 12, 2020

Israeli blood test offers better choices to fight cancer

November 15, 2020

OncoHost Offers New Hope For Cancer Sufferers

December 8, 2020

Dr. Ofer Sharon, CEO of OncoHost – Interview Series

December 31, 2020

OncoHost - Personalized cancer therapy for more effective treatment

January 12, 2021

Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatment

January 19, 2021

Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform

January 19, 2021

Israel-based OncoHost closes $8M in Series B funding to provide personalized cancer therapy for more effective treatment

January 19, 2021

OncoHost Raises $8 Million in Series B Funding Round

January 19, 2021

OncoHost raises $8 million to develop AI that predicts cancer treatment responses

January 20, 2021

OncoHost Secures $8M in Series B Funding

January 20, 2021

The evolution of machine learning in oncology: an interview with Dr Ofer Sharon

January 21, 2021

Money on the Move: January 15-20

January 26, 2020

US-Israel Foundation To Invest $8M In 9 New Joint Initiatives

January 21, 2021

OurCrowd leads $8M Series B in Israeli personalized cancer therapy startup

January 22, 2021

Oncohost nabs $8M series B round for AI-powered precision oncology platform

January 22, 2021

OncoHost Secures $8 Million Series B Funding Round

January 26, 2021

Health IT Appointments and Hires

February 1, 2021

January 2021 smiles upon Israeli startups: 4 new Unicorns and over $1B in funding

February 17, 2021

Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer Care

March 30, 2021

How an AI tool predicts responses to cancer treatment

May 21, 2021

Which Israeli technologies will soon be going to space?

June 14, 2021

The Impact of Technology on Healthcare

June 16, 2021

NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost

June 16, 2021

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

June 16, 2021

NHS opens 8 clinical trial sites to assess cancer treatment

June 17, 2021

Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies

June 22, 2021

Oncohost opens trial sites for study evaluating its AI proteomics profiling technology

July 6, 2021

OncoHost's Focus on the Patient Offers Precision Oncology to Combat Cancer

August 19, 2021

OncoHost awarded Best Practices Technology Innovation Leadership Award in the AI-based precision oncology industry by Frost & Sullivan

August 20, 2021

OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices

August 25, 2021

Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test

September 20, 2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response

September 20, 2021

Oncohost platform predicts response to lung cancer therapy

October 31, 2021

OncoHost’s Algorithms Predict Cancer Patients Response To Treatments

November 1, 2021

CTech’s 20 Minute Leaders Podcast Interview with Ofer Sharon, CEO of OncoHost

November 6, 2021

OncoHost: Personalizing cancer treatment based on host response

November 15, 2021

Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on Cancer Therapy

December 1, 2021

OncoHost: David Gandara

December 7, 2021

Health IT Appointments and Hires

December 13, 2021

OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance

December 12, 2024

“Back to the Future”: Developments in Immunotherapy with David Gandara, MD

December 12, 2024

Health IT Business News

April 25, 2024

Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing

June 20, 2024

New Clinical Study Identifies Personalized Treatment Options for Metastatic NSCLC With Plasma Proteome Testing

September 10, 2024

Proteomics and Prognostics May Serve as Potential Biomarkers Beyond PD-L1 in Lung Cancer

December 6, 2024

In Brief This Week

December 3, 2024

OncoHost Proteomics Lab Earns CAP Accreditation

December 3, 2024

OncoHost earns CAP accreditation for Cary laboratory

November 17, 2024

Bonus Features – November 17, 2024

November 14, 2024

OncoHost announces executive appointment of Ron Andrews

November 13, 2024

OncoHost Strengthens Leadership with Ron Andrews Appointment

November 13, 2024

OncoHost Hires Ron Andrews as Strategic Consultant to the CEO

November 13, 2024

Appointments and advancements for November 13, 2024

October 31, 2024

Editors' and Reader's Choice: 10 Favorite NoCamels Articles

September 13, 2024

OncoHost accepted to present poster at ESMO 2024

August 16, 2024

OncoHost announces three abstracts selected for presentation at WCLC 2024

July 30, 2024

Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection

August 2, 2024

Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

August 5, 2024

Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

July 29, 2024

New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients

June 18, 2024

Immunotherapy Month…and Much More

June 18, 2024

OncoHost: Finding New, Better Immunotherapies for Complex Cancers

May 27, 2024

Israeli Startup To Showcase AI Cancer Tool At Top Oncology Summit

May 27, 2024

PROphet Platform’s Predictive Ability to be Demonstrated

May 31, 2024

OncoHost To Present Poster Demonstrating PROphet®’s Application in Multiple Cancer Indications at ASCO 2024

June 10, 2024

Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research

June 12, 2024

Companies partner to identify biomarkers for renal cell carcinoma

June 3, 2024

OncoHost Launches Study on Biomarkers for Renal Cell Carcinoma

June 3, 2024

OncoHost and Dana-Farber Partner on Kidney Cancer (RCC) Biomarker Study

June 4, 2024

OncoHost announces new study on biomarkers for renal cell carcinoma

June 2, 2024

Leading Cancer institute Dana-Farber to partner with OncoHost for groundbreaking cancer study

May 17, 2024

OncoHost on liquid biopsy, AI, and developing Israel’s life sciences ecosystem

May 20, 2024

Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit

April 10, 2024

AI tool helps doctors pick optimum cancer treatment for patients

March 29, 2024

Observational study demonstrates clinical validity and utility of OncoHost’s PROphet NSCLC test

March 22, 2024

Study in JCO® Precision Oncology Validates Clinical Efficacy of OncoHost’s PROphet® NSCLC Test

March 21, 2024

Study Demonstrates Clinical Validity of OncoHost’s NSCLC Test

March 21, 2024

OncoHost Wins AI Excellence Award

February 26, 2024

Predicting immunotherapy success via biomarkers

February 22, 2024

New cancer research for personalized care

February 22, 2024

Study: Protein Indicates Likely Success of Cancer Immunotherapy

January 26, 2024

OncoHost’s CEO Is PROphet-ic About His Diagnostic’s Potential To Transform Care

January 15, 2024

OncoHost: Guiding oncology treatment decisions with one blood draw

January 4, 2024

Predicting Immune-Related Adverse Events Through Machine Learning With OncoHost: Dr. Waqas Haque, Dr. Matthew Hadfield, and Dr. Ofer Sharon

April 4, 2022

AI & Big Data - A Bright New Diagnosis? Roundtable

December 8, 2019

First-Of-Its-Kind Lab To Improve Personalized Cancer Therapy Opens In Israel

December 31, 2019

Israeli algorithm may predict if cancer patients will respond to treatment

January 21, 2020

OncoHost, RayBiotech Win $1M From BIRD Foundation

January 21, 2020

OncoHost, RayBiotech Awarded $1 Million Grant for Precision Oncology

February 5, 2020

Top 5 Recent Advances In Israeli Cancer Research And Treatment

February 10, 2020

Startup develops blood test that aims to undermine tumors’ resilience

February 18, 2020

Backed by EU funds, Israeli researcher tackles treatment-resistant cancer

February 23, 2020

$8m in BIRD grants go to Israeli-US collaborations in agtech and health

March 1, 2020

Personalized Cancer Treatment, A Real Possibility?

April 7, 2020

Developing Personalized Strategies To Maximize Cancer Therapy Success

June 4, 2020

PART 1: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

June 4, 2020

PART 2: Yuval Shaked, ASCO 2020: Host Response Profiling for Melanoma Patients

August 7, 2020

By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients?

October 6, 2020

OncoHost Data on Host Immunotherapy Response to be Presented This Week

November 4, 2020

Oncohost platform improves immunotherapy response predictions

November 12, 2020

Israeli blood test offers better choices to fight cancer

November 15, 2020

OncoHost Offers New Hope For Cancer Sufferers

December 8, 2020

Dr. Ofer Sharon, CEO of OncoHost – Interview Series

December 31, 2020

OncoHost - Personalized cancer therapy for more effective treatment

January 12, 2021

Nobel prizewinner Ciechanover hails ‘much more precise’ cancer treatment

January 19, 2021

Israeli Startup OncoHost Raises $8M For AI Precision Oncology Platform

January 19, 2021

Israel-based OncoHost closes $8M in Series B funding to provide personalized cancer therapy for more effective treatment

January 19, 2021

OncoHost Raises $8 Million in Series B Funding Round

January 19, 2021

OncoHost raises $8 million to develop AI that predicts cancer treatment responses

January 20, 2021

OncoHost Secures $8M in Series B Funding

January 20, 2021

The evolution of machine learning in oncology: an interview with Dr Ofer Sharon

January 21, 2021

Money on the Move: January 15-20

January 26, 2020

US-Israel Foundation To Invest $8M In 9 New Joint Initiatives

January 21, 2021

OurCrowd leads $8M Series B in Israeli personalized cancer therapy startup

January 22, 2021

Oncohost nabs $8M series B round for AI-powered precision oncology platform

January 22, 2021

OncoHost Secures $8 Million Series B Funding Round

January 26, 2021

Health IT Appointments and Hires

February 1, 2021

January 2021 smiles upon Israeli startups: 4 new Unicorns and over $1B in funding

February 17, 2021

Dr. Ofer Sharon, CEO of OncoHost, Discusses Technology to Improve Cancer Care

March 30, 2021

How an AI tool predicts responses to cancer treatment

May 21, 2021

Which Israeli technologies will soon be going to space?

June 14, 2021

The Impact of Technology on Healthcare

June 16, 2021

NHS opens eight UK clinical trial sites to assess cancer patient response to immunotherapy in collaboration with OncoHost

June 16, 2021

NHS Opens Eight UK Clinical Trial Sites to Assess Cancer Patient Response to Immunotherapy in Collaboration with OncoHost

June 16, 2021

NHS opens 8 clinical trial sites to assess cancer treatment

June 17, 2021

Israel’s OncoHost, UK’s NHS to study cancer patient responses to immunotherapies

June 22, 2021

Oncohost opens trial sites for study evaluating its AI proteomics profiling technology

July 6, 2021

OncoHost's Focus on the Patient Offers Precision Oncology to Combat Cancer

August 19, 2021

OncoHost awarded Best Practices Technology Innovation Leadership Award in the AI-based precision oncology industry by Frost & Sullivan

August 20, 2021

OncoHost Wins Frost & Sullivan 2021 Technology Innovation Leadership Award for Excellence in Best Practices

August 25, 2021

Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test

September 20, 2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response

September 20, 2021

Oncohost platform predicts response to lung cancer therapy

October 31, 2021

OncoHost’s Algorithms Predict Cancer Patients Response To Treatments

November 1, 2021

CTech’s 20 Minute Leaders Podcast Interview with Ofer Sharon, CEO of OncoHost

November 6, 2021

OncoHost: Personalizing cancer treatment based on host response

November 15, 2021

Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on Cancer Therapy

December 1, 2021

OncoHost: David Gandara

December 7, 2021

Health IT Appointments and Hires

December 13, 2021

OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance